Sign in
4

Changes in Ownership

PTC THERAPEUTICS, INC. Filed Acc 0001680329-25-000008

Director sold 15,666 shares at $69.50 ($1,088,787)

  • Director acquired 12,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Reeve Emma · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2025-10-30 Sale : show line 1 in the form 10b5-1 −3,666 $69.50 $254,787 6,666 D
2025-10-30 Exercise or conversion : show line 2 in the form 10b5-1 +12,000 $38.10 $457,200 18,666 D
2025-10-30 Sale : show line 3 in the form 10b5-1 −12,000 $69.50 $834,000 6,666 D
Open-market sales · 15,666 sh · avg $69.50 · $1,088,787

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-10-30 Exercise or conversion : show line 4 in the form 10b5-1 Stock Option (Right to Buy) −12,000 0 D
Loading xslF345X05/form4-10312025_051001.xml…